Video
ZS Principals Mike Moorman, Ty Curry and Erik Long describe how identifying essential sales force effectiveness drivers can deliver organic growth and profits.
Managing Principal Mike Moorman highlights the four major outcomes of sales force transformation.
Principal John Bienko talks about how pharmaceutical companies can measure and maximize returns on their promotional investments.
After ZS helped a pharmaceutical client establish systematic data management processes, data errors and issues disappeared while effort and rework dropped 15%.
Principal Abhijit Nimgaonkar talks about the challenges of maintaining high data quality given the exponential growth of data sources in the pharma industry.
Medical products companies are facing economic and regulatory challenges, and in response, many are implementing new selling models and strategies.
In this video, Managing Principal Kurt Kessler tells the story of a struggling brand that ZS helped re-position in the marketplace with dramatic results.
With the shift to solutions selling and cloud computing, high-tech companies can create a competitive advantage, ZS Principal Ashish Vazirani says in a new video.
Principal Jeff Gold highlights the key components of customer data management that drive revenue growth and reduce costs.
Managing Principal Kurt Kessler talks about how ZS creates pharmaceutical marketing that works – with sophisticated ideas on strategy and a lot of practical experience to make it happen on the ground.
Managing Principal Ty Curry describes how segmentation serves as the foundation for tailoring coverage strategies and allows companies to maximize the value that they deliver to customers.
Principal Judith Kulich describes how pharmaceutical companies entering new markets can create robust forecasts despite budget constraints.
Principal Jeff Gold shares how health care companies are making the most out of their Sunshine Act investments.
The second part of this ZS series examines how pharmaceutical companies can ensure they are taking the right steps when embarking on new sales models in Europe.
Principal Aaron Mitchell addresses how pharmaceutical companies can improve their value proposition development efforts.
« « previous 7 8 9 10 11 12 13 next » »
Medtech Blog
Sales Compensation Blog
Pharma Sales & Marketing Blog
High Tech Sales & Marketing Blog
Asset Management/Insurance Blog
> View all ZS blogs